Introduction to Health Technology Assessment
Author(s)
Faculty: Uwe Siebert, MD, MPH, MSc, ScD, UMIT - University for Health Sciences Medical Informatics and Technology Hall in Tirol, Austria and Harvard Chan School of Public Health Harvard University, Boston, MA, USA
Separate registration required.
This introductory course is designed to teach academic researchers, health policy decision makers, manufacturers, and clinicians about the key elements, methods, and language of health technology assessment (HTA). The course provides an overview of basic HTA principles including benefit assessment (biostatistics, clinical epidemiology, patient-relevant outcomes, risk-benefit assessment), economic evaluation (costing, cost-effectiveness analysis, pharmacoeconomic modeling, budget impact analysis, resource allocation), and ELSI (ethical, legal, and social implications). Using real world examples covering both drugs and devices, the course will review the practical steps involved in developing and using HTA reports in different countries and healthcare systems. Discussion with participants will focus on the implementation of HTA in health care decision making and stakeholder perspectives. This course is suitable for those with little or no experience with HTA.
Conference/Value in Health Info
2024-05, ISPOR 2024, Atlanta, GA, USA
Code
005
Topic
Health Technology Assessment